A novel function of differentiation revealed by cDNA microarray profiling of p75NTR-regulated gene expression

Differentiation

Volumn 73, Issue 8, 2005, Pages 385-396

  Nalbandian, Angèle ^a,b   Pang, Alan L Y ^b   Rennert, Owen M ^b   Chan, Wai Yee ^a,b   Ravindranath, Neelakanta ^c   Djakiew, Daniel ^a,d  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

cDNA microarray; Gene expression profile; p75 neurotrophin receptor; PC 3 prostate tumor cells; Quantitative real time polymerase chain reaction; Retinoic acid; Tumor suppressor gene

Indexed keywords

ALITRETINOIN; CELLULAR RETINOL BINDING PROTEIN 1; COMPLEMENTARY DNA; NEUROTROPHIN RECEPTOR; NITROBLUE TETRAZOLIUM; PLAUR PROTEIN; PROTEIN P75; PROTEIN P75 NTR; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; SOMATOMEDIN BINDING PROTEIN 5; UNCLASSIFIED DRUG; NERVE GROWTH FACTOR RECEPTOR; NERVE PROTEIN; NGFR PROTEIN, HUMAN; RETINOID; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; DIFFERENTIATION; DNA MICROARRAY; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE TUMOR; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; CELL DIFFERENTIATION; GENETICS; MALE; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, RETINOIC ACID; RETINOIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 33645900876     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1111/j.1432-0436.2005.00040.x     Document Type: Article

References (68)

1. Aboseif S.R. Dahiya R. Narayan P. Cunha G.R. ( 1997) Effect of retinoic acid on prostate development. Prostate 31 : 161 167.
2. Alfaro J.M. Fraile B. Lobo M.V. Royuela M. Paniagua R. Arenas M.I. ( 2003) Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate. J Androl 24 : 113 119.
3. Allen J. Khwaja F. Byers S. Djakiew D. ( 2005) The p75(NTR) mediates a bifurcated signal transduction cascade through the NFkappaB and JNK pathways to inhibit cell survival. Exp Cell Res 304 : 69 80.
4. American Cancer Society 2005) Cancer facts & figures 2005. American Cancer Society, Inc, www.cancer.org pp. 4 6.
5. NTR expression. Gene Expres Patterns 3 : 761 765.
6. Bothwell M. ( 1995) Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 18 : 223 253.
7. Breitman T.R. Selonick S.E. Collins S.J. ( 1980) Induction of differentiation of the human promyelocytic leukemia cell line (HL60) by retinoic acid. Proc Natl Acad Sci USA 77 : 2936 2940.
8. Chambon P. ( 1995) The molecular and genetic dissection of the retinoid signal pathway. Recent Prog Horm Res 50 : 317 332.
9. Chambon P. ( 1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10 : 940 954.
10. Chen L.I. Sommer K.M. Swisshelm K. ( 2002) Downstream codons in the retinoic acid receptor beta -2 and beta -4 mRNAs initiate translation of a protein isoform that disrupts retinoid-activated transcription. J Biol Chem 277 : 35411 35421.
11. Cohen P. Peehl D.M. Graves H.C. Rosenfeld R.G. ( 1994) Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 142 : 407 415.
12. Collins S.J. Ruscetti F.W. Gallagher R.E. Gallo R.C. ( 1979) Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med 149 : 969 974.
13. Cunha G.R. Battle E. Young P. Brody J. Donjacour A. Hayashi N. Kinbara H. ( 1992) Role of epithelial-mesenchymal interactions in the differentiation and spatial organization of visceral smooth muscle. Epithelial Cell Biol 1 : 76 83.
14. Cunha G.R. Bigsby R.M. Cooke P.S. Sugimura Y. ( 1985) Stromal-epithelial interactions in adult organs. Cell Differ 17 : 137 148.
15. Cunha G.R. Hayward S.W. Wang Y.Z. Ricke W.A. ( 2003) Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107 : 1 10.
16. Dahiya R. Zhang D.Y. Ho R.J. Haughney P.C. Hayward S.W. Cunha G.R. Narayan P. ( 1995) Regression of LNCaP human prostate tumor xenografts in athymic nude mice by 13-cis-retinoic acid and androgen ablation. Biochem Mol Biol Int 35 : 487 498.
17. De Luca L.M. ( 1991) Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J 5 : 2924 2933.
18. Djakiew D. ( 2000) Dysregulated expression of growth factors and their receptors in the development of prostate cancer. Prostate 42 : 150 160.
19. NTR) during myogenic differentiation. J Cell Physiol 176 : 22 31.
20. Faria T.N. Mendelsohn C. Chambon P. Gudas L.J. ( 1999) The targeted disruption of both alleles of RARbeta(2) in F9 cells results in the loss of retinoic acid-associated growth arrest. J Biol Chem 274 : 26783 26788.
21. Friedman W.J. Greene L.A. ( 1999) Neurotrophin signaling via Trks and p75. Exp Cell Res 253 : 131 142.
22. Gao M. Ossowski L. Ferrari A.C. ( 1999) Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative. J Cell Physiol 179 : 336 346.
23. Gates R.E. Rees R.S. ( 1985) Altered vitamin A-binding proteins in carcinoma of the head and neck. Cancer 56 : 2598 2604.
24. Geisen C. Denk C. Gremm B. Baust C. Karger A. Bollag W. Schwarz E. ( 1997) High-level expression of the retinoic acid receptor β gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor α and is abnormally down-regulated in cervical carcinoma cells. Cancer Res 57 : 1460 1467.
25. Gils A. Declerck P.J. ( 2004) Plasminogen activator inhibitor-1. Curr Med Chem 11 : 2323 2334.
26. Gueddari-Pouzols N. Duriez P. Chomienne C. Trussardi A. Jardillier J.C. ( 2001) Interaction between mevalonate pathway and retinoic acid-induced differentiation. J Biomed Biotechnol 1 : 108 113.
27. Guenette R.S. Tenniswood M. ( 1994) The role of growth factors in the suppression of active cell death in the prostate: an hypothesis. Biochem Cell Biol 72 : 553 559.
28. Halgunset J. Sunde A. Lundmo P.I. ( 1987) Retinoic acid (RA): an inhibitor of 5 alpha-reductase in human prostatic cancer cells. J Steroid Biochem 28 : 731 736.
29. Han H. Bearss D.J. Browne L.W. Calaluce R. Nagle R.B. Von Hoff D.D. ( 2002) Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 62 : 2890 2896.
30. Hansen L.A. Sigman C.C. Andreola F. Ross S.A. Kelloff G.J. De Luca L.M. ( 2000) Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 21 : 1271 1279.
31. Hollas W. Hoosein N. Chung L.W. Mazar A. Henkin J. Kariko K. Barnathan E.S. Boyd D. ( 1992) Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines. Thromb Haemost 68 : 662 666.
32. Huang J. Powell W.C. Khodavirdi A.C. Wu J. Makita T. Cardiff R.D. Cohen M.B. Sucov H.M. Roy-Burman P. ( 2002) Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Res 62 : 4812 4819.
33. Huang M.E. Ye Y.C. Chen S.R. ( 1987) All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia: report of six cases. Chin Med J 100 : 949 953.
34. Jutley J.K. Reaney S. Kelleher J. Whelan P. ( 1990) Interactions of retinoic acid and androgens in human prostatic tissue. Prostate 16 : 299 304.
35. Krygier S. Djakiew D. ( 2001) The neurotrophin receptor p75NTR is a tumor suppressor in human prostate cancer. Anticancer Res 21 : 3749 3755.
36. Krygier S. Djakiew D. ( 2002) Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells. Int J Cancer 98 : 1 7.
37. Leid M. Kastner P. Chambon P. ( 1992) Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 17 : 427 433.
38. Liu D.F. Rabbani S.A. ( 1995) Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC-3. Prostate 27 : 269 276.
39. Lotan R. ( 1995) Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J Natl Cancer Inst 87 : 1655 1657.
40. Lotan R. ( 1996) Retinoids in cancer chemoprevention. FASEB J 10 : 1031 1039.
41. Lotan Y. Xu X.C. Shalev M. Lotan R. Williams R. Wheeler T.M. Thompson T.C. Kadmon D. ( 2000) Differential expression of nuclear retinoid receptors in normal and malignant prostates. J Clin Oncol 18 : 116 121.
42. Mangelsdorf D.J. Thummel C. Beato M. Herrlich P. Schutz G. Umesono K. Blumberg B. Kastner P. Mark M. Chambon P. Evans R.M. ( 1995) The nuclear hormone receptor superfamily: the second decade. Cell 83 : 835 840.
43. Miyake H. Hara I. Yamanaka K. Arakawa S. Kamidono S. ( 1999) Elevation of urokinase-type plasminogen activator and its receptor densities as new predictors of disease progression and prognosis in men with prostate cancer. Int J Oncol 14 : 535 541.
44. Montie J.E. Pienta K.J. ( 1994) Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer. Urology 43 : 892 899.
45. Nagy L. Thomazy V.A. Heyman R.A. Davies P.J. ( 1998) Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ 5 : 11 19.
46. Nason-Burchenal K. Dmitrovsky E. 1999) The retinoid: cancer therapy and prevention mechanisms. In : Nau H. Blaner W.S. (eds.) Retinoids: handbook of experimental pharmacology. Vol. 139, Springer, Berlin, pp. 117 149.
47. Ong D. Newcomer M. Chytil F. ( 1994) Cellular retinoid binding proteins. In : Sporn M. Roberts A. Goodman D. (eds.) The retinoids: biology, chemistry, and medicine. 2nd ed. Raven Press, New York, pp. 288 317.
48. Pang A.L. Taylor H.C. Johnson W. Alexander S. Chen Y. Su Y.A. Li X. Ravindranath N. Dym M. Rennert O.M. Chan W.Y. ( 2003) Identification of differentially expressed genes in mouse spermatogenesis. J Androl 24 : 899 911.
49. Peehl D.M. Wong S.T. Stamey T.A. ( 1993) Vitamin A regulates proliferation and differentiation of human prostatic epithelial cells. Prostate 23 : 69 78.
50. Perez M. Regan T. Pflug B. Lynch J. Djakiew D. ( 1997) Loss of low-affinity nerve growth factor receptor during malignant transformation of the human prostate. Prostate 30 : 274 279.
51. Pflug B.R. Dionne C. Kaplan D.R. Lynch J. Djakiew D. ( 1995) Expression of a Trk high affinity nerve growth factor receptor in the human prostate. Endocrinology 136 : 262 268.
52. Pflug B.R. Onoda M. Lynch J.H. Djakiew D. ( 1992) Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 52 : 5403 5406.
53. Piedrafita F. Pfahl M. ( 1999) Nuclear retinoid receptors and mechanisms of action. In : Nau H. Blaner W. (eds.) Retinoids: handbook of experimental pharmacology. Springer, Berlin, pp. 153 184.
54. Ploug M. Kjalke M. Ronne E. Weidle U. Hoyer-Hansen G. Dano K. ( 1993) Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins. J Biol Chem 268 : 17539 17546.
55. Rabbani S.A. Gladu J. ( 2002) Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo. Cancer Res 62 : 2390 2397.
56. Rabbani S.A. Mazar A.P. ( 2001) The role of the plasminogen activation system in angiogenesis and metastasis. Surg Oncol Clin North Am 10 : 393 415.
57. Rajah R. Bhala A. Nunn S.E. Peehl D.M. Cohen P. ( 1996) 7S nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology 1996 137 : 2676 2682.
58. Roman S.D. Ormandy C.J. Manning D.L. Blamey R.W. Nicholson R.I. Sutherland R.L. Clark C.L. ( 1993) Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res 53 : 5940 5945.
59. Sheng S. ( 2001) The urokinase-type plasminogen activator system in prostate cancer metastasis. Cancer Metastasis Rev 20 : 287 296.
60. Takemasa I. Higuchi H. Yamamoto H. Sekimoto M. Tomita N. Nakamori S. Matoba R. Monden M. Matsubara K. ( 2001) Construction of preferential cDNA microarray specialized for human colorectal carcinoma: molecular sketch of colorectal cancer. Biochem Biophys Res Commun 285 : 1244 1249.
61. Tonner E. Allan G. Shkreta L. Webster J. Whitelaw C.B. Flint D.J. ( 2000) Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland. Adv Exp Med Biol 480 : 45 53.
62. Xie W. Mertens J.C. Reiss D.J. Rimm D.L. Camp R.L. Haffty B.G. Reiss M. ( 2002) Alterations of smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. Cancer Res 62 : 497 505.
63. Xu J. Stolk J.A. Zhang X. Silva S.J. Houghton R.L. Matsumura M. Vedvick T.S. Leslie K.B. Badaro R. Reed S.G. ( 2000) Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 60 : 1677 1682.
64. Xu X.C. Sneige N. Liu X. Nandagiri R. Lee J.J. Lukmanji F. Hortobagyi G. Lippman S.M. Dhingra K. Lotan R. ( 1997a) Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res 57 : 4992 4996.
65. Xu X.C. Sozzi G. Lee J.S. Lee J.J. Pastorino U. Pilotti S. Kurie J.M. Hong W.K. Lotan R. ( 1997b) Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst 89 : 624 629.
66. Yebra M. Goretzki L. Pfeifer M. Mueller B.M. ( 1999) Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. Exp Cell Res 250 : 231 240.
67. Zhang X.K. Hoffmann B. Tran P.B. Graupner G. Pfahl M. ( 1992) Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355 : 441 446.
68. Zhong C. Yang S. Huang J. Cohen M.B. Roy-Burman P. ( 2003) Aberration in the expression of the retinoid receptor, RXRalpha, in prostate cancer. Cancer Biol Ther 2 : 179 184.